ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Ye Mao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0002-2621-0156; OpenAlex author ID A5136498304. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

Current advances in immunotherapy for KRAS-Mutant pancreatic cancer. Last author DOI 10.1007/s10238-026-02201-8 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianbing Wu · 1 shared paper, 2026 · strength 0.36
- Paper Current advances in immunotherapy for KRAS-Mutant pancreatic cancer. DOI 10.1007/s10238-026-02201-8 ↗
M Y Li · 1 shared paper, 2026 · strength 0.36
- Paper Current advances in immunotherapy for KRAS-Mutant pancreatic cancer. DOI 10.1007/s10238-026-02201-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.